ARL3
ADP-ribosylation factor-like protein 3
Also known as: ARFL3, ARL3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P36405
- Gene
- ARL3
- Ensembl
- ENSG00000138175
- Chromosome
- 10
- Canonical length
- 182 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Primary cilium,Centrosome,Basal body
OverviewNCBI Gene
Enables GDP binding activity; GTP binding activity; and microtubule binding activity. Involved in several processes, including cilium assembly; protein localization to cilium; and small GTPase-mediated signal transduction. Acts upstream of or within post-Golgi vesicle-mediated transport. Located in several cellular components, including microtubule cytoskeleton; midbody; and photoreceptor connecting cilium. Implicated in Joubert syndrome and retinitis pigmentosa 83. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
182 residues, UniProt reviewed canonical sequence.
>P36405|ARL3
1 MGLLSILRKL KSAPDQEVRI LLLGLDNAGK TTLLKQLASE DISHITPTQG FNIKSVQSQG
61 FKLNVWDIGG QRKIRPYWKN YFENTDILIY VIDSADRKRF EETGQELAEL LEEEKLSCVP
121 VLIFANKQDL LTAAPASEIA EGLNLHTIRD RVWQIQSCSA LTGEGVQDGM NWVCKNVNAK
181 KKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARL3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 89 nTPM
Expression across tissuesHPA
Tissue
- retina: 89 nTPM
- basal ganglia: 32 nTPM
- cerebral cortex: 30 nTPM
- choroid plexus: 28 nTPM
- amygdala: 27 nTPM
- cerebellum: 25 nTPM
Single-cell type
- fallopian tube ciliated cells: 403 nCPM
- rod photoreceptor cells: 382 nCPM
- respiratory ciliated cells: 306 nCPM
- epididymal efferent duct ciliated cells: 280 nCPM
- endometrial ciliated cells: 268 nCPM
- late primary spermatocytes: 256 nCPM
Immune cell
- neutrophil: 13 nTPM
- MAIT T-cell: 9.4 nTPM
- classical monocyte: 7.2 nTPM
- myeloid DC: 7.1 nTPM
- memory CD4 T-cell: 6.5 nTPM
- intermediate monocyte: 6.2 nTPM
Brain region
- cerebral cortex: 33 nTPM
- basal ganglia: 28 nTPM
- cerebellum: 27 nTPM
- hypothalamus: 27 nTPM
- thalamus: 26 nTPM
- pons: 25 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ARL3.
Disease | AllUniProt
Conditions ARL3 is implicated in, by any mechanism.
- Joubert syndrome 35 (JBTS35) MIM:618161
- Retinitis pigmentosa 83 (RP83) MIM:618173
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 159 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Joubert syndrome 35
- Progressive cone degeneration
- Retinitis pigmentosa 83
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.16
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cilium assembly
- Golgi to plasma membrane transport
- intraciliary transport
- kidney development
- mitotic cytokinesis
- photoreceptor cell development
- post-Golgi vesicle-mediated transport
- protein localization to ciliary membrane
- protein localization to cilium
- protein transport
- small GTPase-mediated signal transduction
- smoothened signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARL3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARL3 as an antibody target. Whether an autoantibody or antibody against ARL3 could matter depends on whether native ARL3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARL3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARL3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...